Burroughs Wellcome & Company

Burroughs Wellcome & Company. Founded in 1880 by American pharmacists Silas Mainville Burroughs and Henry Wellcome, the firm pioneered the marketing of compressed medicines in tablet form and became a global pharmaceutical powerhouse. Its innovative research led to critical drugs for influenza, leprosy, and HIV/AIDS, and its unique corporate structure, the Wellcome Trust, funded vast scientific advancement. The company's legacy endures through its successor, GlaxoSmithKline, and the ongoing philanthropic work of the Wellcome Trust.

History

The partnership was established in London on September 27, 1880, after Burroughs and Wellcome, former colleagues at the American firm McKesson & Robbins, secured backing from a New York City drug importer. A key early innovation was the large-scale introduction of compressed tablet medicines, branded as "Tabloid," a registered trademark that became synonymous with their products. Following the sudden death of Silas Mainville Burroughs in 1895, Henry Wellcome assumed sole control and aggressively expanded operations, establishing research laboratories at Dartford and marketing branches worldwide, including in New York, Montreal, and Bombay. The company's research ethos was solidified with the 1896 founding of the Wellcome Physiological Research Laboratories, attracting scientists like Henry Hallett Dale, who later won the Nobel Prize in Physiology or Medicine. During World War I, the company supplied vital medicines to the British Army and Allied forces, and in 1924, Wellcome created the unique corporate ownership vehicle that would later become the Wellcome Trust.

Notable products

The firm's laboratories were prolific, developing many first-in-class treatments. A major breakthrough came with the 1936 introduction of Sulfanilamide, the first commercially available antibiotic, which revolutionized the treatment of bacterial infections like streptococcus and meningitis. During the Second World War, researchers including D. G. Davey and Frank Hawking developed Paludrine (proguanil), a highly effective synthetic antimalarial used extensively by troops in the Pacific War. Later, the company produced Zovirax (acyclovir), the first successful antiviral for herpes simplex, and, most famously, Retrovir (zidovudine or AZT), the first approved treatment for HIV/AIDS, developed in partnership with the National Cancer Institute. Other significant products included Wellferon for hepatitis C and the Meningitis vaccine Menomune.

Corporate structure and operations

A defining feature was its ultimate ownership by the Wellcome Trust, one of the world's largest biomedical charities. Established from the personal fortune of Henry Wellcome and formalized after his death in 1936, the Trust held all the company's ordinary shares, using dividends to fund scientific research globally. This structure insulated the firm from stock market pressures, allowing long-term investment in basic research. Operationally, it was vertically integrated, controlling production from raw material extraction to finished product distribution. Major manufacturing and research sites included those in Dartford, Beckenham, and Research Triangle Park in North Carolina. The company also had a renowned historical medical collection, the Wellcome Collection, and funded the Wellcome Library. In 1995, it merged with its British rival Glaxo to form GlaxoWellcome, which subsequently merged with SmithKline Beecham in 2000 to create GlaxoSmithKline.

Legacy and impact

Its legacy is profound and twofold: pharmaceutical and philanthropic. As a drug developer, its contributions to infectious disease therapy, from early antibiotics to Retrovir, saved countless lives and shaped modern medicine. The Wellcome Trust, created from the company's wealth, became an independent global charity funding biomedical research, with major contributions to projects like the Human Genome Project and institutions such as the Wellcome Sanger Institute. The Trust's funding has supported Nobel laureates including Francis Crick and Peter Medawar. The company's historical and cultural artifacts form the core of London's Wellcome Collection, a free museum exploring health and human experience. Through GlaxoSmithKline, its direct lineage continues in the pharmaceutical industry, while the Wellcome Trust ensures its founding ethos of advancing human health through research endures independently.

Category:Pharmaceutical companies of the United Kingdom Category:Companies established in 1880 Category:Defunct pharmaceutical companies